Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Chasing the Antidote for Deadly Nerve Agents

by Global Biodefense Staff
March 13, 2020
Chasing the Antidote for Deadly Nerve Agents

A team of scientists may have discovered a new family of antidotes for certain poisons that can mitigate their effects more efficiently compared with existing remedies. Credit: Andrey Kovalevsky | Oak Ridge National Laboratory

In the most comprehensive, structure-based approach to date, a team of scientists may have discovered a new family of antidotes for certain poisons that can mitigate their effects more efficiently compared with existing remedies.

Poisons such as organophosphorus nerve agents and pesticides wreak havoc by blocking an enzyme essential for proper brain and nerve function. Fast-acting drugs, called reactivators, are required to reach the central nervous system and counteract damage that could lead to death.

“To enhance the antidote’s effectiveness, we need to improve the reactivator’s ability to cross the blood-brain barrier, bind loosely to the enzyme, chemically snatch the poison and then leave quickly,” said Oak Ridge National Laboratory’s Andrey Kovalevsky, co-author of a study led by Zoran Radić of UC San Diego.

The team designed and tested reactivators on three different nerve agents and one pesticide with positive initial results. Their next step is to use neutron crystallography to better understand antidote designs.

Tags: Chemical WeaponsEditor PickMagazine Edition 24 March 2020

Related Posts

DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies
Medical Countermeasures

NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC